Literature DB >> 2903937

Catecholamine metabolism in pheochromocytoma and normal adrenal medullae.

T Nakada1, H Furuta, T Katayama.   

Abstract

The tissue contents of catecholamine, its precursor and its major metabolites were determined in 8 human pheochromocytomas and 26 normal adrenal glands. Pheochromocytomas contained significantly larger amounts of norepinephrine, dopamine, dihydroxyphenylalanine, tyrosine hydroxylase activity, metanephrine, normetanephrine and vanillylmandelic acid than did normal adrenal medullae. The content ratio of epinephrine/norepinephrine in normal adrenal medullae was significantly higher than that in pheochromocytomas but there were considerable individual variations in the metanephrine/normetanephrine and vanillylmandelic acid/3-methoxy-4-hydroxyphenylethylglycol ratios in pheochromocytomas. In normal adrenal medullae the tissue content of tyrosine hydroxylase activity correlated inversely with the tissue contents of epinephrine (r equals -0.78, p less than 0.001), norepinephrine (r equals -0.78, p less than 0.001) and total catecholamines (r equals -0.87, p less than 0.001), respectively but no significant relation was found between both parameters in pheochromocytomas. These results indicate the possible presence of a negative feedback mechanism of catecholamine via tyrosine hydroxylase in normal adrenal medullae but none in pheochromocytomas. In addition, the increased degradation catecholamine pathway in pheochromocytomas appears to be unstable compared to that in normal adrenal medullae.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903937     DOI: 10.1016/s0022-5347(17)42041-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma.

Authors:  G Eisenhofer; T T Huynh; M Hiroi; K Pacak
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

2.  Phaeochromocytoma: a catecholamine and oxidative stress disorder.

Authors:  K Pacak
Journal:  Endocr Regul       Date:  2011-04

3.  Catecholamine metabolism in the vas deferens and the adrenal gland with special reference to the central catecholamine-depleted state.

Authors:  T Yamaguchi; T Nakada
Journal:  Experientia       Date:  1992-07-15

4.  Assessment of adrenal surgery on creatinine clearance in patients with phaeochromocytoma.

Authors:  T Nakada; H Kaneko; Y Kubota; M Watanabe; I Sasagawa; T Yagisawa; H Yamanaka; K Imai
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  Central catecholamine, sympathetic nerve and vascular protein in the acute phase of two-kidney, one-clip renovascular hypertension in rats.

Authors:  H Kaneko; T Nakada
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

6.  Effect of the alpha-1 adrenoceptor blocker on tissue norepinephrine contents in human benign prostatic hyperplasia.

Authors:  M Ishigooka; S Hayami; T Hashimoto; Y Suzuki; O Ichiyanagi; T Nakada
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

7.  Norepinephrine contents of human prostatic hyperplasia: differences between pathological subtypes.

Authors:  M Ishigooka; S Hayami; M Tomaru; T Hashimoto; I Sasagawa; T Nakada
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 8.  Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma.

Authors:  Annika M A Berends; Graeme Eisenhofer; Lauren Fishbein; Anouk N A V D Horst-Schrivers; Ido P Kema; Thera P Links; Jacques W M Lenders; Michiel N Kerstens
Journal:  Cancers (Basel)       Date:  2019-08-06       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.